In a pioneering step for India’s biotechnology and precision medicine landscape, the Indian Institute of Technology Madras (IIT-Madras), in collaboration with the Indian Railway Finance Corporation (IRFC), has established the country’s first Single Cell Omics Translational Research Laboratory. The state-of-the-art facility aims to accelerate breakthroughs in genomics, disease biology, and personalized therapeutics.

The new lab will enable researchers to study individual cells at an unprecedented resolution, moving beyond traditional bulk analysis to uncover cellular diversity, disease pathways, and molecular signatures associated with complex conditions such as cancer, neurological disorders, metabolic diseases, and infectious diseases.

Single-cell omics—an advanced branch of molecular biology—helps scientists decode variations among individual cells, leading to deeper insights into disease progression, drug response, and mechanisms of resistance. The translational lab at IIT-Madras is expected to play a critical role in bridging fundamental research with real-world clinical applications.

Supported by IRFC as part of its CSR initiative, the facility will host cutting-edge technologies including single-cell sequencing platforms, advanced imaging systems, and AI-driven bioinformatics tools. These capabilities will empower India’s scientific community to drive high-impact research and contribute to global advancements in precision healthcare.

Researchers anticipate that the lab will foster multidisciplinary collaborations among clinicians, academic scientists, and industry partners, enabling faster development of diagnostics, targeted therapies, and predictive health models. The initiative also aims to build national capacity by training young scientists and clinicians in next-generation omics technologies.

With the launch of this first-of-its-kind research centre, IIT-Madras and IRFC have taken a significant step towards strengthening India’s biotechnology ecosystem and positioning the country as a leader in single-cell research and translational genomics.